Entry Point Capital, LLC Adaptive Biotechnologies Corp Transaction History
Entry Point Capital, LLC
- $171 Million
- Q3 2024
A detailed history of Entry Point Capital, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Entry Point Capital, LLC holds 47,520 shares of ADPT stock, worth $207,662. This represents 0.14% of its overall portfolio holdings.
Number of Shares
47,520Holding current value
$207,662% of portfolio
0.14%Shares
3 transactions
Others Institutions Holding ADPT
# of Institutions
201Shares Held
146MCall Options Held
68.8KPut Options Held
42.5K-
Viking Global Investors LP30MShares$131 Million0.59% of portfolio
-
Rubric Capital Management LP New York, NY14.4MShares$62.9 Million2.05% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$51 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.6MShares$50.7 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$46.5 Million0.0% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $624M
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...